HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stuart M Sprague Selected Research

Hyperphosphatemia

1/2022Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence.
12/2021A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia.
1/2021Small Intestinal Phosphate Absorption: Novel Therapeutic Implications.
1/2020Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.
10/2018Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients.
7/2018Sucroferric oxyhydroxide for the treatment of hyperphosphatemia.
1/2018Should phosphate management be limited to the KDIGO/ KDOQI guidelines?
1/2017Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
2/2016Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
6/2015Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stuart M Sprague Research Topics

Disease

35Chronic Renal Insufficiency
12/2021 - 05/2004
23Hyperphosphatemia
01/2022 - 07/2002
20Secondary Hyperparathyroidism
01/2019 - 07/2002
14Bone Diseases (Bone Disease)
08/2021 - 05/2002
12Hypercalcemia (Milk Alkali Syndrome)
01/2017 - 07/2002
11Kidney Diseases (Kidney Disease)
11/2017 - 05/2004
8Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
08/2021 - 07/2002
6Inflammation (Inflammations)
01/2020 - 07/2010
5Renal Insufficiency (Renal Failure)
11/2008 - 05/2002
4Diarrhea
12/2021 - 09/2014
4Vascular Calcification
08/2021 - 01/2007
4Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 12/2007
4Chronic Kidney Failure (Chronic Renal Failure)
10/2015 - 07/2002
3Hypocalcemia
08/2021 - 11/2002
3Nausea
10/2018 - 09/2014
3Constipation
10/2018 - 09/2014
3Hyperparathyroidism
01/2014 - 12/2007
3Vitamin D Deficiency
12/2010 - 01/2007
2Albuminuria
10/2019 - 07/2010
2Type 2 Diabetes Mellitus (MODY)
10/2019 - 12/2018
2Vomiting
10/2018 - 11/2017
2Hypophosphatemia
02/2013 - 01/2008
1Iron Overload
01/2020
1Heart Failure
10/2019
1Bone Resorption
01/2019
1Weight Loss (Weight Reduction)
12/2018
1Body Weight (Weight, Body)
12/2018
1Rheumatoid Arthritis
02/2017
1Experimental Arthritis
02/2017
1Arthritis (Polyarthritis)
02/2017
1Sepsis (Septicemia)
02/2017
1Calciphylaxis
01/2016
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
10/2015
1Hypoxia (Hypoxemia)
01/2015
1Neoplasms (Cancer)
09/2014
1Obesity
01/2014
1Skin Ulcer
01/2014
1Cardiomyopathies (Cardiomyopathy)
02/2013
1Pruritus (Itching)
02/2013
1Osteonecrosis (Kienbock's Disease)
02/2013
1Muscular Diseases (Myopathy)
02/2013
1Anemia
02/2013
1Hypertension (High Blood Pressure)
07/2010
1Insulin Resistance
07/2010
1Malnutrition (Nutritional Deficiencies)
07/2010
1Metabolic Bone Diseases (Osteopenia)
07/2009
1Hyperplasia
12/2007

Drug/Important Bio-Agent (IBA)

21MineralsIBA
08/2021 - 05/2002
20Parathyroid Hormone (Parathormone)IBA
08/2021 - 05/2002
17Phosphates (Orthophosphate)IBA
12/2021 - 11/2002
14Phosphorus (Red Phosphorus)IBA
01/2021 - 01/2003
13Vitamin DFDA LinkGeneric
08/2021 - 07/2002
13CalciumIBA
10/2018 - 11/2002
9sucroferric oxyhydroxideIBA
01/2022 - 06/2015
9Calcitriol (Calcijex)FDA LinkGeneric
09/2014 - 07/2002
7Sevelamer (RenaGel)FDA Link
01/2020 - 12/2007
6paricalcitol (Zemplar)FDA Link
09/2014 - 04/2003
5IronIBA
12/2021 - 08/2017
4Fibroblast Growth Factor-23IBA
08/2021 - 06/2015
4Calcitriol Receptors (Calcitriol Receptor)IBA
01/2017 - 01/2008
3Calcifediol (Calcidiol)FDA Link
01/2017 - 01/2014
3Cinacalcet (Sensipar)FDA Link
06/2015 - 01/2003
2Hormones (Hormone)IBA
08/2021 - 02/2013
2bardoxolone methylIBA
10/2019 - 12/2018
225-hydroxyvitamin DIBA
01/2019 - 02/2016
2Furosemide (Lasix)FDA LinkGeneric
12/2015 - 01/2015
2Alkaline PhosphataseIBA
09/2014 - 07/2010
2Diphosphonates (Bisphosphonates)IBA
01/2014 - 02/2013
2lanthanum carbonate (Fosrenol)FDA Link
01/2009 - 12/2007
21 alpha-hydroxyergocalciferol (doxercalciferol)FDA Link
11/2005 - 05/2004
1ferrous sulfateFDA Link
01/2020
1Methylcellulose (BFL)IBA
01/2020
1ferric citrateIBA
01/2020
1AlbuminsIBA
10/2019
1CreatinineIBA
10/2019
1Tartrate-Resistant Acid PhosphataseIBA
01/2019
1HematinicsIBA
08/2017
1Hemoglobins (Hemoglobin)IBA
08/2017
1Peptide Hydrolases (Proteases)FDA Link
02/2017
1Granzymes (Granzyme)IBA
02/2017
1PerforinIBA
02/2017
1CytokinesIBA
02/2017
1Collagen Type II (Type II Collagen)IBA
02/2017
1TabletsIBA
06/2015
1Advanced Glycation End ProductsIBA
06/2014
1Warfarin (Coumadin)FDA LinkGeneric
01/2014
1sodium thiosulfateFDA Link
01/2014
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
02/2013
1Biomarkers (Surrogate Marker)IBA
07/2010
1Proteins (Proteins, Gene)FDA Link
07/2010
1ReninIBA
07/2010
1Pharmaceutical PreparationsIBA
01/2009

Therapy/Procedure

17Therapeutics
12/2021 - 01/2003
6Kidney Transplantation
01/2020 - 01/2004
6Renal Dialysis (Hemodialysis)
06/2015 - 01/2003
3Peritoneal Dialysis
06/2015 - 01/2008
2Transplantation
12/2018 - 01/2006
1Oral Administration
01/2020
1Glycemic Control
12/2018
1Parathyroidectomy
01/2016